A study has found that stopping GLP-1 medications may lead to a loss of cardiovascular benefits, potentially increasing the risk of heart attack, stroke, and death. The benefits of these medications, which include weight loss drugs like Ozempic, appear to fade quickly after they are stopped, with weight also rebounding. The long-term effectiveness of GLP-1s is being questioned, with some studies raising red flags over their sustained heart health benefits.